InvestorsHub Logo
Followers 23
Posts 3749
Boards Moderated 0
Alias Born 05/15/2014

Re: None

Wednesday, 07/29/2020 8:09:42 AM

Wednesday, July 29, 2020 8:09:42 AM

Post# of 647877
RGLS - Regulus Therapeutics Announces FDA Orphan Drug Designation of RGLS4326 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.